SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-041803
Filing Date
2020-12-09
Accepted
2020-12-09 16:15:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea131100-s3_protaratherap.htm S-3 513585
2 OPINION OF COOLEY LLP ea131100ex5-1_protaratherap.htm EX-5.1 35650
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea131100ex23-1_protaratherap.htm EX-23.1 3209
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea131100ex23-2_protaratherap.htm EX-23.2 2088
5 GRAPHIC img_001.jpg GRAPHIC 7058
6 GRAPHIC ex5-1_001.jpg GRAPHIC 7801
  Complete submission text file 0001213900-20-041803.txt   576414
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251224 | Film No.: 201378005
SIC: 2836 Biological Products, (No Diagnostic Substances)